March 2013 

HPS Successfully Defends Infectious Disease Specialist

Partner David Hall obtained a defense verdict in favor of an infectious disease specialist related to plaintiff's allegations that he should have insured the patient did not resume taking Allopurinol, a gout medication, following discharge from the hospital. After discharge, the patient developed a full-body desquamating skin condition known as toxic epidermal necrolysis, overwhelming sepsis and died after unsuccessful treatment in the burn unit. Defense argued the defendant’s role was to determine whether the patient’s condition was from an infection and that specialists not consulted by the primary service had expertise in diagnosing a drug reaction. Plaintiff asked the jury for $25 Million.